The Center for Technology Licensing's (CTL) mission is to bring the University's scientific discoveries, technological innovations, and medical advances to the marketplace for societal benefit and to foster economic development within New York State and across the nation.
Licensing
CTL is industry's link to Cornell's broad range of innovative research that is available for licensing. Over the years, Cornell technologies have been licensed to industry partners all over the world in support of Cornell's land-grant mission and to develop these technologies and plant varieties into products and services for public good.
Available Cornell Technologies
- Novel Therapeutic Approaches for the Treatment of Laminopathies
- Bioluminescent Reporters for Monitoring of Calcium-related Activity
- MousePadâ¢: An Inexpensive, User-friendly, and Non-Invasive Mouse Physiology Monitoring System
- An MIR-PANEL for Distinguishing Benign from Malignant Thyroid Nodules
- Molecular Barcoding Tools and Methods for Spatial Mapping of Complex Microbial Communities with Single-Cell Resolution
- High-affinity Chelators for Rapid Dissolution of Barium Sulfate Deposits and Capture of Radioactive Materials
Current Featured Technologies
- » Biomarkers for Predicting & Diagnosing Cancer/Metastasis
- » Accommodating Intraocular Lens & Conversion Plate
- » White Wine Grape ‘Aromella’
- » Generic Programmable Tag
- » Reversible Small Molecule Immunoproteasome Inhibitors
- » Red Wine Grape ‘Arandell’
- » Tethered Enzyme Technology (TET™) Point-of-Care Testing for Brain Injuries